The Relative Strength (RS) Rating for Trupanion climbed into a higher percentile Tuesday, as it got a lift from 67 to 77.
This proprietary rating measures market leadership by using a 1 (worst) to 99 (best) score that shows how a stock's price performance over the trailing 52 weeks compares to other publicly traded companies.
Decades of market research reveals that the best stocks tend to have an RS Rating of at least 80 in the early stages of their moves. See if Trupanion can continue to rebound and hit that benchmark.
When To Sell Stocks To Lock In Profits And Minimize Losses
Trupanion has climbed more than 5% past a 36.66 entry in a first-stage consolidation, meaning it's now out of a proper buy zone. Look for the stock to offer a new buying opportunity like a three-weeks tight or pullback to the 50-day or 10-week line.
Trupanion posted 0% EPS growth last quarter, while sales growth came in at 14%.
Trupanion earns the No. 4 rank among its peers in the Insurance-Accident & Healthcare industry group. Aflac is the top-ranked stock within the group.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
RELATED:
Which Stocks Are Showing Rising Relative Strength?
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
